Stock Fundamentals

Company Information

Company Name
Y mAbs Therapeutics
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US9842411095
CIK: 0001722964
CUSIP: 984241109
Currency: USD
Full Time Employees: 104
Phone: 646 885 8505
Fiscal Year End: December
IPO Date: Sep 21, 2018
Description:

Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of radioimmunotherapy and antibody based therapeutic products for the treatment of cancer. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment of pediatric patients with relapsed or refractory high-risk neuroblastoma in the bone or bone marrow. The company also develops DANYELZA for the treatment of patients with second-line relapsed osteosarcoma and is in Phase II clinical study; GD2-SADA, which is in Phase I clinical trial for the treatment of GD2 positive solid tumors; and Omburtamab, an antibody for the treatment of central nervous system/leptomeningeal metastases from neuroblastoma. In addition, it engages in the development of CD38-SADA and GD2-GD3 Vaccine; and offers self-assembly disassembly pretargeted radioimmuno therapy (SADA PRIT) technology platform to deliver the radioactive payload to the tumor. The company has a license agreement with Memorial Sloan Kettering Cancer Center and Massachusetts Institute of Technology to develop and commercialize licensed products. It operates in the United States, Western Europe, Eastern Asia, Latin America, Western Asia, and internationally. Y-mAbs Therapeutics, Inc. was incorporated in 2015 and is headquartered in Princeton, New Jersey. As of September 15, 2025, Y-mAbs Therapeutics, Inc. operates as a subsidiary of SERB S.A.S.

Address:

202 Carnegie Center, Princeton, NJ, United States, 08540

Directors & Officers

Name Title Year Born
Mr. Michael Rossi CEO, President & Director 1971
Mr. Thomas Gad Founder, Chief Business Officer & Vice Chairman 1970
Mr. Peter P. Pfreundschuh CPA Executive VP, CFO & Treasurer 1969
Mr. Joris Wiel Jan Wilms Senior VP & COO 1974
Dr. Torben Lund-Hansen M.Sc., Ph.D. Senior VP & CTO 1951
Ms. Courtney Dugan VP & Head of Investor Relations NA
Mr. John W. LaRocca Esq. Senior VP, General Counsel, Secretary & Chief Legal Officer 1965
Dr. Norman D. LaFrance FACNP, FACP, M.D. Chief Development Officer & Chief Medical Officer 1948
Mr. Doug Gentilcore Senior VP & Head of DANYELZA Business Unit 1980
Ms. Natalie Tucker Senior VP & Radiopharmaceutical Business Unit Head NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Mar 07, 2025 Michael J Rossi N/A Sale 3.92K $5.20 $20.37K
Mar 07, 2025 Thomas Gad N/A Sale 10.81K $5.23 $56.54K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Paradigm Biocapital Advisors LP 4.24M Jun 30, 2025 9.32% $0.82 0.00%
BlackRock Inc 2.75M Jun 30, 2025 6.05% $0.00 -5.30%
Caligan Partners LP 2.34M Jun 30, 2025 5.16% $2.03 0.00%
Sofinnova Ventures 2.19M Jun 30, 2025 4.83% $0.61 0.00%
Vanguard Group Inc 1.94M Jun 30, 2025 4.28% $0.00 -0.17%
Polar Capital Holdings PLC 1.79M Jun 30, 2025 3.94% $0.04 -2.25%
Geode Capital Management, LLC 848.46K Jun 30, 2025 1.87% $0.00 -0.12%
State Street Corp 780.15K Jun 30, 2025 1.72% $0.00 -1.12%
BOOTHBAY FUND MANAGEMENT, LLC 693.69K Jun 30, 2025 1.53% $0.06 0.00%
D. E. Shaw & Co LP 516.86K Jun 30, 2025 1.14% $0.00 -5.97%
Dimensional Fund Advisors, Inc. 412.25K Jun 30, 2025 0.91% $0.00 -1.51%
Nantahala Capital Management, LLC 351.88K Jun 30, 2025 0.77% $0.06 0.00%
Soleus Capital Management, L.P. 349.98K Jun 30, 2025 0.77% $0.10 0.00%
Northern Trust Corp 308.13K Jun 30, 2025 0.68% $0.00 -6.03%
Morgan Stanley - Brokerage Accounts 292.57K Jun 30, 2025 0.64% $0.00 -41.51%
Stonepine Capital Management Llc 285.30K Jun 30, 2025 0.63% $1.26 117.52%
Charles Schwab Investment Management Inc 278.18K Jun 30, 2025 0.61% $0.00 0.21%
Bank of America Corp 274.16K Jun 30, 2025 0.60% $0.00 -2.89%
AQR Capital Management LLC 252.14K Jun 30, 2025 0.55% $0.00 53.01%
UBS Group AG 229.07K Jun 30, 2025 0.50% $0.00 150.14%

Shares Statistics

Shares Outstanding: 45.44M
Shares Float: 18.89M
% Insiders: 1,197.30%
% Institutions: 8,277.70%
Short % Float: 4.83%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 HBM Healthcare Investments AG Ord 3.30M 7.26% ▲ 0.00% Jun 30, 2025
2 Polar Capital Biotech S Inc 1.78M 3.93% ▲ 0.00% Jul 31, 2025
3 Vanguard Total Stock Mkt Idx Inv 1.02M 2.24% ▼ 2.16% Jul 31, 2025
4 iShares Russell 2000 ETF 897.24K 1.97% ▲ 0.00% Aug 31, 2025
5 Fidelity Small Cap Index 372.35K 0.82% ▼ 2.72% Jun 30, 2025
6 Vanguard Institutional Extnd Mkt Idx Tr 355.66K 0.78% ▼ 29.00% Jul 31, 2025
7 iShares Russell 2000 Growth ETF 311.23K 0.68% ▲ 0.00% Aug 31, 2025
8 iShares Biotechnology ETF 202.86K 0.45% ▲ 0.00% Aug 31, 2025
9 Fidelity Extended Market Index 182.61K 0.40% ▼ 0.82% Jul 31, 2025
10 Vanguard Russell 2000 ETF 175.90K 0.39% ▼ 6.16% Jul 31, 2025

Valuation Metrics

Enterprise Value: $332.06M
Trailing P/E: 0.00
Forward P/E: 119.05

Financial Highlights

Market Cap: $391.22M
EBITDA: $-17.77M
Book Value: $1.93
Earnings/Share: $-0.50
Profit Margin: -26.03%
Operating Margin: -28.70%
ROA (TTM): -8.67%
ROE (TTM): -24.31%
Revenue (TTM): $85.39M
Revenue/Share (TTM): $1.90
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -14.40%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2024-12-31 4.16x 0.01x 0.23x N/A -0.02x
2023-12-31 5.52x 0.02x 0.21x N/A -0.07x
2022-12-31 4.61x 0.02x 0.23x -125.25x -0.02x
2021-12-31 7.26x 0.02x 0.15x -62.33x -0.03x
2020-12-31 6.26x 0.04x 0.20x -200.56x -0.03x
2019-12-31 15.60x 0.01x 0.08x -42.01x -0.01x
2018-12-31 16.61x 0.00x 0.08x -982.50x 0.00x
2017-12-31 11.53x 0.00x 0.11x N/A 0.00x
2016-12-31 5.80x 0.00x 0.30x N/A 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about YMAB.US!